Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.

Respiratory syncytial virus (RSV) causes serious illness (lower respiratory illness) in preterm infants. RSV antibody-enriched immunoglobulin (RSVIG) that was lyophilized (LYO) protected against RSV lower respiratory illness. The Food and Drug Administration now requires an additional viral inactiva...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Groothuis, J R, Simoes, E A, Lehr, M V, Kramer, A A, Hemming, V G, Rodriguez, W J, Arrobio, J, Welliver, R C, Siber, G R
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1995
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793870/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.668
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!